Phage display screening services offer powerful and efficient solutions for selecting and engineering proteins, peptides, or antibodies with desired properties. This technology leverages bacteriophages to display libraries of protein variants on their surface, facilitating high-throughput screening and selection based on binding affinity, specificity, and stability. Our comprehensive services provide support from initial library construction to final candidate selection, ensuring that your screening projects achieve precise and reliable results.
The general scheme of phage display technique and biopanning selection of high affinity peptide. (PE Saw, et al.,2019)
Phase Display Screening is a technique used to screen and identify proteins or peptides with specific functions. It utilizes phage display technology to display multiple variants of target proteins or peptides, and identifies variants with specific performance or activity through screening.
The experimental method process is as follows:
Through this process, proteins or peptides with specific functions can be quickly and efficiently screened, providing important experimental techniques for drug research, biological research, and other fields.
The process of phage display screening involves several critical and interrelated steps:
For more information about our Phage Display Screening Services or to discuss your specific needs, please contact us. Our team of experts is available to provide guidance and support for your research and biotechnological projects, ensuring you achieve your scientific and industrial goals.
The following table provides an overview of various case studies in phage display screening and the solutions we offer to support your research and biotechnological endeavors:
Case Study | Description | Solutions We Offer |
---|---|---|
Therapeutic Antibody Discovery | Selecting antibodies with high affinity and specificity for therapeutic use. | Library construction, phage display, screening, and hit identification. |
Peptide Ligand Discovery | Identifying peptides that bind specific targets with high affinity for therapeutic or diagnostic purposes. | Synthetic library design, biopanning, and binding assays. |
Enzyme Variant Selection | Discovering enzyme variants with improved catalytic efficiency and thermal stability. | Random mutagenesis, high-throughput screening, and functional assays. |
Protein Interaction Mapping | Identifying and enhancing protein-protein interactions for signaling studies. | Library construction, screening, and interaction assays. |
Epitope Mapping for Vaccine Development | Mapping epitopes on antigens to aid in vaccine design. | Phage display library creation, epitope screening, and validation. |
Receptor-Ligand Binding Studies | Engineering receptors with improved ligand binding or altered signaling properties. | Directed evolution, screening, and functional characterization. |
A: Phage display screening is a technique that utilizes bacteriophages to display libraries of peptides, proteins, or antibodies on their surface, allowing for high-throughput screening and selection of variants based on binding affinity, specificity, and stability. This method is widely used for protein engineering and directed evolution.
A: Phage display screening is performed through a series of steps including project consultation, library construction, phage display library creation, screening and selection, hit identification, characterization and validation, optimization and iteration, and reporting. Each step ensures the efficient and accurate selection of molecules with desired properties.
A: Applications include antibody discovery and engineering, peptide library screening, enzyme engineering, protein-protein interaction studies, ligand binding studies, and vaccine development. Phage display screening provides powerful tools for improving and optimizing protein functions.
A: Key steps include project consultation, library construction, phage display library creation, screening and selection, hit identification, characterization and validation, optimization and iteration, and reporting. These steps ensure comprehensive and reliable screening of protein or peptide variants.
A: Phage display screening is important for advancing research, developing new therapies, and improving industrial processes. It enables the high-throughput identification and optimization of molecules with enhanced properties, leading to innovative solutions in biotechnology and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.